#USA #Minneapolis #Bio-Techne #diagnostics #RD Systems

Bio-Techne Unveils Streamlined Brand Architecture

Bio-Techne Corporation (NASDAQ: TECH), renowned for its cutting-edge life science research solutions, has freshly introduced an innovative brand architecture designed to assist scientists and clinicians in navigating their diverse offerings more efficiently. This strategy aims to enhance the clarity with which users can access the resources necessary for their research and clinical endeavors.

Overview of the Brand Architecture

In this new structure, Bio-Techne organizes its extensive range of products and services into three dedicated portfolio brands:
1. RD Systems™
2. Bio-Techne Spatial™
3. Bio-Techne Diagnostics™

This focused approach not only simplifies the navigation of Bio-Techne's products but also aligns closely with the scientific process from initial discovery, through translational insights, to final clinical decision-making. Kim Kelderman, President and CEO of Bio-Techne, emphasized that this restructuring reflects the company's commitment to facilitating breakthroughs in science and medicine by meeting the evolving needs of researchers and clinicians alike.

Highlights of the Brand Portfolios

RD Systems™

The RD Systems portfolio consolidates a wealth of Bio-Techne's pioneering technologies, including high-quality proteins, antibodies, small molecules, and innovative instruments. These tools are indispensable for scientists engaged in early-stage research, as they enable reproducibility and validation of findings. Furthermore, RD Systems supports advancements in cell and gene therapy, providing GMP-grade reagents essential for significant breakthroughs in these fields.

Bio-Techne Spatial™

Next, the Bio-Techne Spatial portfolio leverages advanced technologies like the RNAscope™ in situ hybridization and the automated COMET™ spatial hyperplex platform. This brand focuses on translating complex biological and disease contexts into actionable insights, offering researchers the ability to visualize RNA and proteins at high resolutions. Such capabilities are crucial for identifying clinically relevant biomarkers and addressing pivotal questions in pathology and therapeutic development.

Bio-Techne Diagnostics™

The Bio-Techne Diagnostics portfolio is tailored for clinical laboratories and in vitro diagnostics (IVD) manufacturers. It encompasses a wide range of assay kits, molecular controls, antibodies, and proficiency-testing materials designed to ensure the reliability and development of diagnostic assays. This portfolio plays a vital role throughout the lifecycle of assay development, enhancing accuracy and supporting informed clinical decisions that ultimately lead to improved patient outcomes.

Moving Forward with Enhanced Accessibility

With these three interconnected portfolios, Bio-Techne seeks to create a streamlined journey for its customers—facilitating access to necessary tools as they progress from scientific discovery to clinical application. By doing so, the company intends not only to maintain its status as a trusted partner for scientific professionals but also to inspire confidence in the tools and technologies it offers.

Upcoming Conferences

Bio-Techne plans to showcase its newly aligned brand architecture at significant upcoming scientific gatherings, including the American Association for Cancer Research (AACR) Annual Meeting in San Diego and IMMUNOLOGY 2026™ in Boston. These events will be crucial in demonstrating the company’s commitment to advancing scientific progress and improving health outcomes.

About Bio-Techne

Founded in Minnesota over 50 years ago, Bio-Techne stands as a global leader in providing top-quality reagents, analytical instruments, and precision diagnostics. With operations in 34 locations worldwide and a workforce of approximately 3,100 professionals, the company reported over $1.2 billion in net sales in fiscal year 2025. Bio-Techne's extensive product line serves a diverse clientele including academic researchers, biotechnology firms, and clinical laboratories.

For further details about Bio-Techne and its new brand structure, visit Bio-Techne's official website or follow them on social media platforms like LinkedIn, X, and YouTube.